Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Amanta Healthcare IPO is a book build issue of ₹126.00 crores. The issue is entirely a fresh issue of 1.00 crore shares of ₹126.00 crore.
Amanta Healthcare IPO bidding started from Sep 1, 2025 and ended on Sep 3, 2025. The allotment for Amanta Healthcare IPO was finalized on Sep 4, 2025. Amanta Healthcare IPO will list on BSE, NSE with a tentative listing date fixed as Sep 9, 2025.
Amanta Healthcare IPO price band is set at ₹126.00 per share . The lot size for an application is 119. The minimum amount of investment required by an retail is ₹14,994 (119 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,666 shares), amounting to ₹2,09,916, and for bNII, it is 67 lots (7,973 shares), amounting to ₹10,04,598.
Beeline Capital Advisors Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Amanta Healthcare IPO RHP for detailed Information.
| IPO Date | September 1, 2025 to September 3, 2025 |
| Listing Date | September 9, 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹120 to ₹126 per share |
| Issue Price Final | ₹126 per share |
| Lot Size | 119 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,00,00,000 shares (aggregating up to ₹126.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,88,29,351 shares |
| Share Holding Post Issue | 3,88,29,351 shares |
Amanta Healthcare IPO offers total 1,00,00,000 shares. Out of which 50,00,000 (50.00%) allocated to QIB, 20,00,000 (20.00%) allocated to QIB (Ex- Anchor), 15,00,000 (15.00%) allocated to NII, 35,00,000 (35.00%) allocated to RII and 30,00,000 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 50,00,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 30,00,000 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 20,00,000 (20.00%) | NA |
| NII (HNI) Shares Offered | 15,00,000 (15.00%) | NA |
| − bNII > ₹10L | 10,00,000 (10.00%) | 600 |
| − sNII < ₹10L | 5,00,000 (5.00%) | 300 |
| Retail Shares Offered | 35,00,000 (35.00%) | 29,411 |
| Total Shares Offered | 1,00,00,000 (100.00%) |
Amanta Healthcare IPO raises ₹37.80 crore from anchor investors. Amanta Healthcare IPO Anchor bid date is August 29, 2025. Amanta Healthcare IPO Anchor Investors list
| Bid Date | August 29, 2025 |
| Shares Offered | 30,00,000 |
| Anchor Portion Size (In Cr.) | 37.80 |
| Anchor lock-in period end date for 50% shares (30 Days) | October 4, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | December 3, 2025 |
Amanta Healthcare IPO opens on September 1, 2025, and closes on September 3, 2025.
| IPO Open Date | Mon, Sep 1, 2025 |
| IPO Close Date | Wed, Sep 3, 2025 |
| Tentative Allotment | Thu, Sep 4, 2025 |
| Initiation of Refunds | Mon, Sep 8, 2025 |
| Credit of Shares to Demat | Mon, Sep 8, 2025 |
| Tentative Listing Date | Tue, Sep 9, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Sep 3, 2025 |
Investors can bid for a minimum of 119 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
Experienced management team supported by a large, diverse and skilled workforce.
Amanta Healthcare Ltd.'s revenue decreased by 2% and profit after tax (PAT) rose by 189% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
| Amount in ₹ Crore | |||
The market capitalization of Amanta Healthcare IPO is ₹489.25 Cr.
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
The Company Amanta Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | 70.00 |
| 2 | Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | 30.13 |
| 3 | General corporate purposes | 6.60 |
[Dilip Davda] AHL is engaged in developing/manufacturing/marketing diverse range of sterile liquid pharma products. It posted almost static top lines for the reported periods. It suffered for FY23 and FY24 on account MAT incentive reversals and other related adjustments. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears exorbitantly priced. Only well-informed/cash surplus investors may park moderate funds for medium term/ others can stay away. Read detail review...
| Listing Date | September 9, 2025 |
| BSE Script Code | 544502 |
| NSE Symbol | AMANTA |
| ISIN | INE084K01015 |
| Final Issue Price | ₹126 per share |
| BSE Listing Group | T |
Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: amantahealthcare.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Amanta Healthcare IPO is a main-board IPO of 1,00,00,000 equity shares of the face value of ₹10 aggregating up to ₹126.00 Crores. The issue is priced at ₹126 per share. The minimum order quantity is 119.
The IPO opens on September 1, 2025, and closes on September 3, 2025.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Amanta Healthcare IPO using UPI as a payment gateway. Zerodha customers can apply in Amanta Healthcare IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Amanta Healthcare IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Amanta Healthcare IPO opens on September 1, 2025 and closes on September 3, 2025.
Amanta Healthcare IPO lot size is 119, and the minimum amount required for application is ₹14,994.
You can apply in Amanta Healthcare IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Amanta Healthcare IPO will be done on Thursday, September 4, 2025, and the allotted shares will be credited to your demat account by Monday, September 8, 2025. Check the Amanta Healthcare IPO allotment status.
The Amanta Healthcare IPO listing date is on Tuesday, September 9, 2025.
Useful Articles
RHP